Award
NIH Reporter #3U19NS132301-04S1
LEAD PROJECT 1: PHENYLKETONURIA (PKU)
Recipient
Children's Hospital of Philadelphia
Award Amount
$5,455,342.00
Ceiling
$5,455,342.00
Awarded
August 19, 2026
Identifier
3U19NS132301-04S1
Funding supports development of lipid nanoparticle adenine base-editing treatments for PKU and urea cycle disorders, including planned clinical trial preparation.
Description
Development of lipid nanoparticle-based adenine base-editing treatments for phenylketonuria or urea cycle disorders, with the goal of filing IND applications and conducting a phase I/II master protocol clinical trial for subjects with urea cycle disorders.